These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease]. Juhász M; Tulassay Z Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107 [TBL] [Abstract][Full Text] [Related]
69. PPIs and fracture risk. Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458 [No Abstract] [Full Text] [Related]
70. [Proton pump inhibitors (PPI): may be not as harmless as believed]. Reinberg O Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997 [TBL] [Abstract][Full Text] [Related]
71. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A; Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285 [TBL] [Abstract][Full Text] [Related]
72. Common questions about the management of gastroesophageal reflux disease. Anderson WD; Strayer SM; Mull SR Am Fam Physician; 2015 May; 91(10):692-7. PubMed ID: 25978198 [TBL] [Abstract][Full Text] [Related]
73. [How to choose correct proton pump inhibitors to patients with GERD?]. Bordin DS Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811 [TBL] [Abstract][Full Text] [Related]
74. Safety of proton pump inhibitor exposure. Yang YX; Metz DC Gastroenterology; 2010 Oct; 139(4):1115-27. PubMed ID: 20727892 [TBL] [Abstract][Full Text] [Related]
75. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
76. Gastroesophageal reflux disease management and chronic use of proton pump inhibitors. Howland AM JAAPA; 2023 Dec; 36(12):1-6. PubMed ID: 37989196 [TBL] [Abstract][Full Text] [Related]
77. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274 [TBL] [Abstract][Full Text] [Related]
78. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?]. Simon M; Zerbib F Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391 [TBL] [Abstract][Full Text] [Related]
79. Pre-dinner administration increases the efficacy of proton pump inhibitors on refractory GERD symptoms in connective tissue disease patients. Iwata A; Ikeda K; Hirose K; Takatori H; Takahashi K; Sanayama Y; Tanaka S; Suto A; Nakajima H Mod Rheumatol; 2013 Mar; 23(2):357-64. PubMed ID: 22614239 [TBL] [Abstract][Full Text] [Related]
80. PPI therapy: when to worry about fracture risk. Heidelbaugh JJ J Fam Pract; 2011 May; 60(5):255-60. PubMed ID: 21544271 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]